Pituitary/growth disorders
NEWS
- NEWS
- December 5, 2023
Vosoritide may be given to children with achondroplasia aged under 60 months after phase 2 trial findings point to a tolerable adverse event profile and an increase in height Z score compared with placebo.
- NEWS
- October 4, 2023
Exome sequencing and chromosomal microarray analysis are useful tools for the identification of genetic causes underlying short stature, indicate the results of a systematic review and meta-analysis.
- NEWS
- October 4, 2023
Gonadotropin-releasing hormone agonist therapy in children with congenital adrenal hyperplasia does not compromise bone mineral density, US researchers say.
- NEWS
- September 5, 2023
The Guideline Development Group has created a set of UK guidelines to aid clinicians in the diagnosis and treatment of children and young people with adamantinomatous craniopharyngiomas.
In depth
- MEETING
- September 5, 2023
We are delighted to announce the upcoming Springer Healthcare IME Symposium, entitled Insights into MAnaging Growth for Endocrine Nurses (IMAGE). This meeting will take place on the 21–22 March 2024 at the Westminster Hotel and Spa, Nice, France.
- MEETING
- February 9, 2023
This is the 9th IMAGE programme, which focuses on transgender management, bone health, and the genetics and treatment of growth disorders.
- PODCAST
- December 20, 2022
Professor Martin Savage discusses the roles of clinical, endocrinological and genetic testing in the diagnosis and care of children with idiopathic short stature.
- REVIEW
- October 31, 2022
Why is the growth plate the most important organ for childhood growth: how can it be investigated for clinical diagnosis?
